A recent study also confirmed that the addition of CD40 antibody to irreversible electroporation (IRE) could improve DC activation and neoantigen recognition in a mouse model, while generating a strong systemic anti-tumor T cell response [87]. The gene discussed is CD40; the disease is neoplasm.